title: Comment on 'Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia'.
authors.affiliation: Department of Hospital Medicine, Haaglanden Medical Center (HMC), The Hague, The Netherlands.|Department of Internal Medicine, Haaglanden Medical Center (HMC), The Hague, The Netherlands.
authors.forename: W H
authors.initials: WH
authors.lastname: Tong
mesh_terms: D000328:Adult; D018033:Antibodies, Bispecific; D000970:Antineoplastic Agents; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma
chemical_list: D018033:Antibodies, Bispecific; D000970:Antineoplastic Agents; C510808:blinatumomab